Galbraith Kenneth
Chair & CEO at ZYME; Director at MGNX
- Sold, on record
- $5M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Jan 12, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MGNXUnusualSep 9 2020
Sold 20,773 shares at $27.11 ($563k)
Galbraith Kenneth, Director
Sold 100% of holdings ($563k position)0 shares leftFirst sale on recordFiling
- 2 Form 144 notice ZYMENoticeJan 5 +1213 days
Filed to sell 23,904 shares ($252k)
Galbraith Kenneth, Officer, Director
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale ZYMEUnusualJan 8 +3 days
Sold 23,904 shares at $10.79 ($258k)
Galbraith Kenneth, Chair & CEO
No 10b5-1 planSold 50.1% of holdings ($514k position)23,762 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 4 sale ZYMEUnusualJan 6 +364 days
Sold 57,291 shares at $14.92 ($855k)
Galbraith Kenneth, Chair & CEO
No 10b5-1 planSold 41.5% of holdings ($2.1M position)80,803 shares leftFiling
- 5 Form 4 sale ZYMEUnusualDec 22 +350 days
Sold 47,528 shares at $27.02 ($1.3M)
Galbraith Kenneth, Chair & CEO
No 10b5-1 planSold 26.3% of holdings ($4.9M position)133,275 shares leftFiling
- 6 Form 4 sale ZYMENo planJan 5 +14 days
Sold 54,343 shares at $25.10 ($1.4M)
Galbraith Kenneth, Chair & CEO
No 10b5-1 planSold 21.9% of holdings ($6.2M position)193,266 shares leftFiling
- 7 Form 4 sale ZYMENo planJan 12 +7 days
Sold 30,424 shares at $22.67 ($690k)
Galbraith Kenneth, Chair & CEO
No 10b5-1 planSold 11.8% of holdings ($5.8M position)226,842 shares left0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | ZYME | Chair & CEO | Form 4 sale | 30,424 | $690k | 11.8% | No plan | SEC |
| Jan 5, 2026 | ZYME | Chair & CEO | Form 4 sale | 54,343 | $1.4M | 21.9% | No plan | SEC |
| Dec 22, 2025 | ZYME | Chair & CEO | Form 4 sale | 47,528 | $1.3M | 26.3% | Unusual | SEC |
| Jan 6, 2025 | ZYME | Chair & CEO | Form 4 sale | 57,291 | $855k | 41.5% | Unusual | SEC |
| Jan 8, 2024 | ZYME | Chair & CEO | Form 4 sale | 23,904 | $258k | 50.1% | Unusual | SEC |
| Jan 5, 2024 | ZYME | Officer, Director | Form 144 notice | 23,904 | $252k | Notice | SEC | |
| Sep 9, 2020 | MGNX | Director | Form 4 sale | 20,773 | $563k | 100.0% | Unusual | SEC |